Nicola Mackie

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Sheena McCormack, David Dunn, Monica Desai et al. · The Lancet · 2015 · 1.9K citations · Full text

Public Health, Pharmacotherapy, Preventive Medicine +14

British HIV Association guidelines for the treatment of <scp>HIV</scp>‐1‐positive adults with antiretroviral therapy 2015

Duncan Churchill, Laura Waters, Nadia Ahmed et al. · HIV Medicine · 2016 · 126 citations

Pharmacy, Pharmacotherapy, Good Clinical Practice +12

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

Catherine Orrell, Debbie Hagins, Elena Belonosova et al. · The Lancet HIV · 2017 · 118 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Persistence of HIV-1 Transmitted Drug Resistance Mutations

Hannah Castro, Deenan Pillay, Patricia Cane et al. · The Journal of Infectious Diseases · 2013 · 113 citations · Full text

Medicine, Molecular Genetics, Pharmacology +17

Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men

H Lamba, David Goldmeier, Nicola Mackie et al. · International Journal of STD & AIDS · 2004 · 85 citations

Medicine, Endocrinology, Andrology +16